Incyte
INCY
#979
Rank
โ‚ฌ21.85 B
Marketcap
107,24ย โ‚ฌ
Share price
1.39%
Change (1 day)
16.94%
Change (1 year)

Operating Margin for Incyte (INCY)

Operating Margin as of November 2026 (TTM): 13.24%

According to Incyte's latest financial reports and stock price the company's current Operating Margin is 13.24%. At the end of 2022 the company had an Operating Margin of 15.67%.

Operating Margin history for Incyte from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202215.67%-18.27%
202119.17%-322.18%
2020-8.63%-138.11%
201922.64%264.42%
20186.21%-131.25%
2017-19.88%-250.4%
201613.22%87.41%
20157.05%-2198.53%
2014-0.34%-97.3%
2013-12.45%-2034.52%
20120.64%-100.42%
2011-151.59%-1932.98%
20108.27%-100.55%
2009-1,508.56%-62.88%
2008-4,064.53%1541.45%
2007-247.62%-10.95%
2006-278.06%-78.35%
2005-1,284.53%22.07%
2004-1,052.26%329.61%
2003-244.93%154.2%
2002-96.35%226.54%
2001-29.51%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Novartis
NVS
22.03% 66.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.01%-9.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
40.21% 203.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
27.00% 103.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
59.29% 347.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-45.40%-442.90%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-172.37%-1,401.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-30.78%-332.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-12.30%-192.90%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.